Trial Profile
Efficacy of Decentralized Care in the Management of Patients With Hepatitis C in a Public Health Care Setting: The Punjab Model
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Jun 2021
Price :
$35
*
At a glance
- Drugs Daclatasvir (Primary) ; Ledipasvir (Primary) ; Ribavirin (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 10 Apr 2018 New trial record